Moderna gets full FDA approval for vaccine
Moderna has now received full FDA approval for its COVID-19 vaccine, the second vaccine maker to be granted full approval, after Pfizer.
All three vaccines currently available in the U.S. were granted emergency authorization based on large clinical studies and at least two months of safety data.
Moderna said the full approval was "based on a comprehensive submission package including efficacy and safety data approximately six months after second dose."
-ABC News' Sony Salzman